Risk Factors for Tumor Size Increase During Active Surveillance of Papillary Thyroid Cancer: Meta-Analysis and Systematic Review
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background and Objectives The purpose of this study was to systematically review literatureson active surveillance for low-risk differentiated thyroid cancer, and to evaluate risk factorsfor tumor size increase during active surveillance. Subjects and Method We conducted a systematic review and a meta-analysis of studies reportingon tumor growth during active surveillance of papillary thyroid cancer. Using theMEDLINE and EMBASE databases, we searched studies published from the inception of databaseto December 2020. Studies were included if reported on at least one clinical risk parameterin addition to reporting on the change in tumor size during active surveillance. Results Out of 33 studies screened, seven were included in the meta-analysis. The odds ratioof a temporal size increase of more than 3 mm in papillary thyroid cancer was 0.011 person-years (95% confidence interval [CI]: 0.009 to 0.013). The odds ratio of lymph node metastasiswas 0.002 person-years (95% CI: 0.001 to 0.003). Younger age was a significant riskfactor for tumor growth during active surveillance, with a standardized median difference of-0.63 (95% CI: -1.00 to -0.27). In the three studies that evaluated the association of thyroidstimulatinghormone levels and tumor size, the results were contradictory. Conclusion Active surveillance may be used more cautiously for younger patients.
Abstract
Background and Objectives The purpose of this study was to systematically review literatureson active surveillance for low-risk differentiated thyroid cancer, and to evaluate risk factorsfor tumor size increase during active surveillance. Subjects and Method We conducted a systematic review and a meta-analysis of studies reportingon tumor growth during active surveillance of papillary thyroid cancer. Using theMEDLINE and EMBASE databases, we searched studies published from the inception of databaseto December 2020. Studies were included if reported on at least one clinical risk parameterin addition to reporting on the change in tumor size during active surveillance. Results Out of 33 studies screened, seven were included in the meta-analysis. The odds ratioof a temporal size increase of more than 3 mm in papillary thyroid cancer was 0.011 person-years (95% confidence interval [CI]: 0.009 to 0.013). The odds ratio of lymph node metastasiswas 0.002 person-years (95% CI: 0.001 to 0.003). Younger age was a significant riskfactor for tumor growth during active surveillance, with a standardized median difference of-0.63 (95% CI: -1.00 to -0.27). In the three studies that evaluated the association of thyroidstimulatinghormone levels and tumor size, the results were contradictory. Conclusion Active surveillance may be used more cautiously for younger patients.
참고문헌 (39)
- Canaris GJ, "The Colorado thyroid disease prevalence study", Arch Intern Med, 160(4), pp.526~534 (2000)
- 정규원, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2009", Cancer Research and Treatment, 44(1), pp.11~24 (2012), 대한암학회
- Cho BY, "Changes in the clinicopathological characteristics and outcomes of thyroid cancer in Korea over the past four decades", Thyroid, 23(7), pp.797~804 (2013)
- Kent WD, "Increased incidence of differentiated thyroid carcinoma and detection of subclinical disease", CMAJ, 177(11), pp.1357~1361 (2007)
- Pathak KA, "The changing face of thyroid cancer in a population-based cohort", Cancer Med, 2(4), pp.537~544 (2013)
- Enewold L, "Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005", Cancer Epidemiol Biomarkers Prev, 18(3), pp.784~791 (2009)
- Ito Y, "Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation", Thyroid, 24(1), pp.27~34 (2014)
- Haugen BR, "2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer : The American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer", Thyroid, 26(1), pp.1~133 (2016)
- Alhashemi A, "A systematic review of primary active surveillance management of low-risk papillary carcinoma", Curr Opin Oncol, 28(1), pp.11~17 (2016)
- Moher D, "Preferred reporting items for systematic reviews and metaanalyses : The PRISMA statement", PLoS Med, 6(7), pp.e1000097~ (2009)
- Liberati A, "The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: Explanation and elaboration", BMJ, 339, pp.b2700~ (2009)
- Higgins JP, "Measuring inconsistency in meta-analyses", BMJ, 327(7414), pp.557~560 (2003)
- Sterne JA, "Publication and related bias in meta-analysis : Power of statistical tests and prevalence in the literature", J Clin Epidemiol, 53(11), pp.1119~1129 (2000)
- Sugitani I, "Association between serum thyrotropin concentration and growth of asymptomatic papillary thyroid microcarcinoma", World J Surg, 38(3), pp.673~678 (2014)
- Tuttle RM, "Natural history and tumor volume kinetics of papillary thyroid cancers during active surveillance", JAMA Otolaryngol Head Neck Surg, 143(10), pp.1015~1020 (2017)
- Kwon H, "Active surveillance for patients with papillary thyroid microcarcinoma : A single center’s experience in Korea", J Clin Endocrinol Metab, 102(6), pp.1917~1925 (2017)
- Kim HI, "High serum TSH level is associated with progression of papillary thyroid microcarcinoma during active surveillance", J Clin Endocrinol Metab, 103(2), pp.446~451 (2018)
- Sakai T, "Active surveillance for T1bN0M0 papillary thyroid carcinoma", Thyroid, 29(1), pp.59~63 (2019)
- Oh HS, "Active surveillance of low-risk papillary thyroid microcarcinoma : A multi-center cohort study in Korea", Thyroid, 28(12), pp.1587~1594 (2018)
- Miyauchi A, "Estimation of the lifetime probability of disease progression of papillary microcarcinoma of the thyroid during active surveillance", Surgery, 163(1), pp.48~52 (2018)
- Fukuoka O, "Natural history of asymptomatic papillary thyroid microcarcinoma : Time-dependent changes in calcification and vascularity during active surveillance", World J Surg, 40(3), pp.529~537 (2016)
- Miyauchi A, "Clinical trials of active surveillance of papillary microcarcinoma of the thyroid", World J Surg, 40(3), pp.516~522 (2016)
- Cho MA, "Expression and role of estrogen receptor alpha and beta in medullary thyroid carcinoma : Different roles in cancer growth and apoptosis", J Endocrinol, 195(2), pp.255~263 (2007)
- Derwahl M, "Estrogen and its role in thyroid cancer", Endocr Relat Cancer, 21(5), pp.T273~83 (2014)
- Farahati J, "Characteristics of differentiated thyroid carcinoma in children and adolescents with respect to age, gender, and histology", Cancer, 80(11), pp.2156~2162 (1997)
- Li N, "Impact of enhanced detection on the increase in thyroid cancer incidence in the United States: Review of incidence trends by socioeconomic status within the surveillance, epidemiology, and end results registry, 1980-2008", Thyroid, 23(1), pp.103~110 (2013)
- Messuti I, "Impact of pregnancy on prognosis of differentiated thyroid cancer : Clinical and molecular features", Eur J Endocrinol, 170(5), pp.659~666 (2014)
- Zahedi A, "Risk for thyroid cancer recurrence is higher in men than in women independent of disease stage at presentation", Thyroid, 30(6), pp.871~877 (2020)
- Takano T, "Natural history of thyroid cancer", Endocr J, 64(3), pp.237~244 (2017)
- Kowalski LP, "Long-term survival rates in young patients with thyroid carcinoma", Arch Otolaryngol Head Neck Surg, 129(7), pp.746~749 (2003)
- Ito Y, "Prognosis and prognostic factors of differentiated thyroid carcinoma after the appearance of metastasis refractory to radioactive iodine therapy", Endocr J, 61(8), pp.821~824 (2014)
- Lee DY, "Changes of clinicopathologic characteristics and survival outcomes of anaplastic and poorly differentiated thyroid carcinoma", Thyroid, 26(3), pp.404~413 (2016)
- Lee DY, "Recurrence and survival after gross total removal of resectable undifferentiated or poorly differentiated thyroid carcinoma", Thyroid, 26(9), pp.1259~1268 (2016)
- Takano T, "Fetal cell carcinogenesis : A new hypothesis for better understanding of thyroid carcinoma", Thyroid, 15(5), pp.432~438 (2005)
- 최영준, "Inter-Observer Variation in Ultrasound Measurement of the Volume and Diameter of Thyroid Nodules", Korean Journal of Radiology, 16(3), pp.560~565 (2015), 대한영상의학회[DOI]
- Lubitz CC, "Annual financial impact of welldifferentiated thyroid cancer care in the United States", Cancer, 120(9), pp.1345~1352 (2014)
- Lang BH, "A cost-effectiveness comparison between early surgery and non-surgical approach for incidental papillary thyroid microcarcinoma", Eur J Endocrinol, 173(3), pp.367~375 (2015)
- Oda H, "Comparison of the costs of active surveillance and immediate surgery in the management of low-risk papillary microcarcinoma of the thyroid", Endocr J, 64(1), pp.59~64 (2017)
- Venkatesh S, "Cost-effectiveness of active surveillance versus hemithyroidectomy for micropapillary thyroid cancer", Surgery, 161(1), pp.116~126 (2017)